Biogen’s rollercoaster 2021 takes another surprising turn with report of $42B Samsung buyout interest

Samsung Group is in talks to buy Biogen in a deal that could be worth $42 billion, the Korea Economic Daily reported Wednesday, citing investment banking sources.

If the report is true—and if negotiations succeed—Samsung would take control of Biogen at a time when the biotech is laboring to…